Rothlauer
Biomalife ButirBioma 30 capsules
Biomalife ButirBioma 30 capsules
Couldn't load pickup availability
Dietary supplement based on sodium butyrate.
Modified-release tablets.
The intestinal barrier
The intestinal barrier is the largest interface and contact surface between our organism and the outside world. It acts as an extremely precise, active filter and protective mechanism, distinguishing nutrients and beneficial substances from potentially harmful antigens and microorganisms.
The heart of the intestinal barrier is the epithelium. This consists of the intestinal cells, which are firmly connected to each other by tight junctions, and the protective mucus layer that covers and protects these cells.
Various factors can damage the intestinal barrier: the protective mucus layer becomes thinner and is absent or interrupted in places; the tight junctions open and there are spaces between the cells (leaky gut syndrome).
These spaces allow antigens, toxins and bacteria to penetrate the intestinal barrier and enter the gut-associated immune system (GALT).
The GALT reacts to these foreign bodies and activates immune cells that secrete pro-inflammatory substances.
This inflammation of the intestine aggravates the already existing disruption of the intestinal barrier, as in a vicious circle.
- Gluten-free
- naturally lactose-free
- without sweeteners
- No added sugar
- without preservatives
Suitable for:
- Children from 6 years of age
- Vegetarian
- during pregnancy and breastfeeding
Active ingredients
Sodium butyrate
Sodium butyrate is the sodium salt of butyric acid, a short-chain fatty acid that is produced during the microbial fermentation of dietary fiber in the intestine.
Butyrate is the preferred source of food and energy for the cells that make up the intestinal barrier.
Modified active ingredient release
To ensure optimal release of sodium butyrate throughout the intestine, BUTIRBIOMA uses modified active ingredient release technology: the tablets are enteric-coated and slow-release.
A patent has been filed for the special manufacturing process of these film-coated tablets, which protects and illustrates its uniqueness.
Release tests
In vitro tests have been carried out, which mimic the conditions in the stomach and in the small and large intestines. These prove the following process of active ingredient release: The BUTIRBIOMA tablets survive the acidic environment of the stomach unscathed, the disintegration of the tablets begins in the duodenum and thus the gradual dissolution of the butyrate, the release of the active ingredient continues throughout the intestinal tract and ends in the large intestine. This achieved release kinetics is crucial for the high efficacy of the product.
Recommended use
Take up to 3 tablets daily, preferably with a meal, with a little water.
You can take the product for several months.
Ingredients
Averages | Per tablet | Per 3 tablets (max. daily dose) |
---|---|---|
Sodium Butyrate | 625 mg | 1876 mg |
of which butyrate | 500 mg | 1501 mg |
SODIUM BUTYRATE, STABILIZER: HYDROXYPROPYL METHYLCELLULOSE; ACIDITY REGULATOR: CALCIUM CARBONATE; GLAZING AGENTS: ETHYLCELLULOSE, HYDROXYPROPYL CELLULOSE, TALC, SODIUM ALGINATE, MEDIUM CHAIN TRIGLYCERIDES, POLYETHYLENE GLYCOL, FATTY ACIDS; STABILIZER: SORBITOL; ACIDITY REGULATOR: CALCIUM HYDROXIDE; CORNSTARCH; ANTI-CAKING AGENTS: CALCIUM SALTS OF FATTY ACIDS, SILICON DIOXIDE; DYE: CALCIUM CARBONATE; THICKENERS: GUAR GUM, SODIUM ALGINATE.
Usually ships out within 3-4 business days
Share
